Find out all the information about the upcoming DRAGON conference in Brussels, 1–2 June.
As part of the DRAGON project, this event will gather experts from across the field of respiratory medicine. It will provide an overview of the best diagnosis and prediction models implemented for acute and long COVID-19. It will outline the use of AI and machine learning to deliver a patient-centred decision support system for rapid and precise diagnosis and prognosis. There will also be discussions on how the world is prepared for future pandemics.
DRAGON is an Innovative Medicines Initiative (IMI) project and ELF and ERS are involved in it as partners.
A limited number of seats are still available to join this free event from 1–2 June in Brussels.
Register now to secure your attendance!
This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 101005122. The JU receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. More information is available at: https://www.imi.europa.eu/.
Copyright – DRAGON -The communication reflects the author’s view and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79